Key Appointments Management Team

TargED Biopharmaceuticals is very pleased to announce the appointment of Dr. Josefin-Beate Holz as Chief Medical Officer and Gerben van ‘t Klooster as Chief Development Officer.

Kristof Vercruysse, CEO commented: “We are thrilled to welcome Josi and Gerben to our team at TargED Biopharmaceuticals. Both bring a wealth of experience and expertise that will be invaluable to our efforts to develop our innovative therapy for patients suffering from Thrombosis.”